ABBOTT LABORATORIES

ABBOTT PARK, IL How do I update this listing?

Abbott Laboratories is based out of Abbott Park. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. In March 2012, STARLIMS Technologies, an Abbott company, acquired STARLIMS's French distributor Varilab; operations of two privately held Spanish businesses, operating as STARLIMS Iberica; a Dutch company, operating as STARLIMS Netherlands, with a branch office in Solna, Sweden; and the business of its Israeli distribution partner, STARLIMS Israel, Ltd. In addition, the Company established STARLIMS Germany GmbH, with offices in Witten, Germany. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company.Whalewisdom has at least 13 13D filings, 10 13G filings, and 1106 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2011-03-15. The notice included securities offered of Debt

Create Email Alert

Contact Info

abbott laboratories
100 ABBOTT PARK ROAD
ABBOTT PARK IL    60064-3500

Business Phone: 2246676100
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2011-03-15 D PHARMACEUTICALS Debt 100,000 100,000 0
2010-03-12 D PHARMACEUTICALS Debt 70,000 70,000 0
2009-03-13 D PHARMACEUTICALS Debt 6,690,000 6,690,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
A. DAVID FORREST subscription required
    EXECUTIVE OFFICER
BOONE POWELL JR. subscription required
    DIRECTOR
BRIAN J. BLASER subscription required
    EXECUTIVE OFFICER
CARLOS ALBAN subscription required
    EXECUTIVE OFFICER
DAVID A. L. OWEN subscription required
    DIRECTOR
DONALD V. PATTON JR. subscription required
    EXECUTIVE OFFICER
EDWARD M. LIDDY subscription required
    DIRECTOR
EDWARD L. MICHAEL subscription required
    EXECUTIVE OFFICER
GLENN F. TILTON subscription required
    DIRECTOR
GREG W. LINDER subscription required
    EXECUTIVE OFFICER
H. LAURANCE FULLER subscription required
    DIRECTOR
HEATHER L. MASON subscription required
    EXECUTIVE OFFICER
HOLGER A. LIEPMANN subscription required
    EXECUTIVE OFFICER
J. SCOTT WHITE subscription required
    EXECUTIVE OFFICER
JAMES V. MAZZO subscription required
    EXECUTIVE OFFICER
JAMES L. TYREE subscription required
    EXECUTIVE OFFICER
JOHN M. CAPEK subscription required
    EXECUTIVE OFFICER
JOHN C. LANDGRAF subscription required
    EXECUTIVE OFFICER
LAURA J. SCHUMACHER subscription required
    EXECUTIVE OFFICER
MARY T. SZELA subscription required
    EXECUTIVE OFFICER
MICHAEL J. WARMUTH subscription required
    EXECUTIVE OFFICER
MILES D. WHITE subscription required
    EXECUTIVE OFFICER
OLIVIER BOHUON subscription required
    EXECUTIVE OFFICER
PHEBE N. NOVAKOVIC subscription required
    DIRECTOR
RICHARD W. ASHLEY subscription required
    EXECUTIVE OFFICER
RICHARD A. GONZALEZ subscription required
    EXECUTIVE OFFICER
ROBERT J. ALPERN subscription required
    DIRECTOR
ROBERT B. HANCE subscription required
    EXECUTIVE OFFICER
ROXANNE S. AUSTIN subscription required
    DIRECTOR
ROY S. ROBERTS subscription required
    DIRECTOR
SAMUEL C. SCOTT III subscription required
    DIRECTOR
STEPHEN R. FUSSELL subscription required
    EXECUTIVE OFFICER
THOMAS F. CHEN subscription required
    EXECUTIVE OFFICER
THOMAS C. FREYMAN subscription required
    EXECUTIVE OFFICER
W. JAMES FARRELL subscription required
    DIRECTOR
W. ANN REYNOLDS subscription required
    DIRECTOR
WILLIAM M. DALEY subscription required
    DIRECTOR
WILLIAM A. OSBORN subscription required
    DIRECTOR
WILLIAM D. SMITHBURG subscription required
    DIRECTOR

**EXPERIMENTAL** Current UK Positions

Updated daily

Contains transactions from January 1st, 2015 on.

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
ABBOTT LABORATORIES Allergy Therapeutics PLC 2015-11-20 240,584,571 40.995%

Position History

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights

Elevate your investments